These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

913 related items for PubMed ID: 17382165

  • 1. Significance of primary tumor size and preorchiectomy serum tumor marker level in predicting pathologic stage at retroperitoneal lymph node dissection in clinical Stage A nonseminomatous germ cell tumors.
    Beck SD, Foster RS, Bihrle R, Donohue JP.
    Urology; 2007 Mar; 69(3):557-9. PubMed ID: 17382165
    [Abstract] [Full Text] [Related]

  • 2. [Efficacy of modified retroperitoneal lymph node dissection for testicular nonseminomatous germ cell tumors].
    Liu ZW, Zhou FJ, Han H, Qin ZK, Yu SL, Li YH, Ye YL, Teng XY.
    Ai Zheng; 2008 Dec; 27(12):1302-6. PubMed ID: 19079998
    [Abstract] [Full Text] [Related]

  • 3. Outcome analysis for patients with elevated serum tumor markers at postchemotherapy retroperitoneal lymph node dissection.
    Beck SD, Foster RS, Bihrle R, Einhorn LH, Donohue JP.
    J Clin Oncol; 2005 Sep 01; 23(25):6149-56. PubMed ID: 16135481
    [Abstract] [Full Text] [Related]

  • 4. Significance of elevated preoperative alpha-fetoprotein in postchemotherapy residual tumor resection for the disseminated germ cell tumors.
    Kobayashi T, Kawakita M, Terachi T, Habuchi T, Ogawa O, Kamoto T.
    J Surg Oncol; 2006 Dec 01; 94(7):619-23. PubMed ID: 17111392
    [Abstract] [Full Text] [Related]

  • 5. Viable malignant germ cell tumor in the postchemotherapy retroperitoneal lymph node dissection specimen: can it be predicted using clinical parameters?
    Spiess PE, Brown GA, Pisters LL, Liu P, Tu SM, Evans JG, Kamat AM, Black P, Tannir NM.
    Cancer; 2006 Oct 01; 107(7):1503-10. PubMed ID: 16944534
    [Abstract] [Full Text] [Related]

  • 6. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
    Rabbani F, Gleave ME, Coppin CM, Murray N, Sullivan LD.
    Cancer; 1996 Aug 01; 78(3):480-6. PubMed ID: 8697394
    [Abstract] [Full Text] [Related]

  • 7. The case for observation of patients with clinical stage I nonseminomatous germ cell testicular tumors.
    Swanson DA.
    Semin Urol; 1993 May 01; 11(2):92-8. PubMed ID: 7689741
    [No Abstract] [Full Text] [Related]

  • 8. Recurrence in nonseminomatous germ cell testis tumor patients with no viable tumor at postchemotherapy retroperitoneal lymph node dissection.
    Spiess PE, Tannir NM, Brown GA, Liu P, Tu SM, Evans JG, Pisters LL.
    Urology; 2007 Dec 01; 70(6):1173-8. PubMed ID: 18158041
    [Abstract] [Full Text] [Related]

  • 9. The management of patients with clinical stage I nonseminomatous testicular tumors and persistently elevated serologic markers.
    Saxman SB, Nichols CR, Foster RS, Messemer JE, Donohue JP, Einhorn LH.
    J Urol; 1996 Feb 01; 155(2):587-9. PubMed ID: 8558665
    [Abstract] [Full Text] [Related]

  • 10. Delayed orchiectomy at postchemotherapy retroperitoneal lymph node dissection due to laterality of retroperitoneal metastatic pattern consistent with testicular primary: assessment of pathologic findings.
    Brown JA, Bihrle R, Foster RS.
    Urology; 2008 May 01; 71(5):911-4. PubMed ID: 18342916
    [Abstract] [Full Text] [Related]

  • 11. Does the presence of extranodal extension in pathological stage B1 nonseminomatous germ cell tumor necessitate adjuvant chemotherapy?
    Beck SD, Cheng L, Bihrle R, Donohue JP, Foster RS.
    J Urol; 2007 Mar 01; 177(3):944-6. PubMed ID: 17296383
    [Abstract] [Full Text] [Related]

  • 12. Primary retroperitoneal lymph node dissection in patients with clinical stage IS testis cancer.
    Williams SB, Steele GS, Richie JP.
    J Urol; 2009 Dec 01; 182(6):2716-20. PubMed ID: 19836777
    [Abstract] [Full Text] [Related]

  • 13. Complications of primary nerve sparing retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumors of the testis: experience of the German Testicular Cancer Study Group.
    Heidenreich A, Albers P, Hartmann M, Kliesch S, Kohrmann KU, Krege S, Lossin P, Weissbach L, German Testicular Cancer Study Group.
    J Urol; 2003 May 01; 169(5):1710-4. PubMed ID: 12686815
    [Abstract] [Full Text] [Related]

  • 14. Retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer: impact of patient selection factors on outcome.
    Stephenson AJ, Bosl GJ, Motzer RJ, Kattan MW, Stasi J, Bajorin DF, Sheinfeld J.
    J Clin Oncol; 2005 Apr 20; 23(12):2781-8. PubMed ID: 15837993
    [Abstract] [Full Text] [Related]

  • 15. [Clinical studies of testicular tumor. II. Analysis of 30 patients with nonseminomatous testicular tumor].
    Tsukamoto T, Kumamoto Y, Ohmura K, Tsunekawa T, Yamazaki K.
    Hinyokika Kiyo; 1986 Jul 20; 32(7):999-1011. PubMed ID: 2430437
    [Abstract] [Full Text] [Related]

  • 16. Tumor marker levels in post-chemotherapy cystic masses: clinical implications for patients with germ cell tumors.
    Beck SD, Patel MI, Sheinfeld J.
    J Urol; 2004 Jan 20; 171(1):168-71. PubMed ID: 14665869
    [Abstract] [Full Text] [Related]

  • 17. Factors that influence the results of salvage surgery in patients with chemorefractory germ cell carcinomas with elevated tumor markers.
    Habuchi T, Kamoto T, Hara I, Kawai K, Nakao M, Nonomura N, Kobayashi T, Ogawa O, Kamidono S, Akaza H, Okuyama A, Kato T, Miki T.
    Cancer; 2003 Oct 15; 98(8):1635-42. PubMed ID: 14534879
    [Abstract] [Full Text] [Related]

  • 18. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell tumor: a large single institution experience.
    Hyams ES, Pierorazio P, Proteek O, Sroka M, Kavoussi LR, Allaf ME.
    J Urol; 2012 Feb 15; 187(2):487-92. PubMed ID: 22177913
    [Abstract] [Full Text] [Related]

  • 19. Incidence of disease outside modified retroperitoneal lymph node dissection templates in clinical stage I or IIA nonseminomatous germ cell testicular cancer.
    Eggener SE, Carver BS, Sharp DS, Motzer RJ, Bosl GJ, Sheinfeld J.
    J Urol; 2007 Mar 15; 177(3):937-42; discussion 942-3. PubMed ID: 17296380
    [Abstract] [Full Text] [Related]

  • 20. American Society of Clinical Oncology Clinical Practice Guideline on uses of serum tumor markers in adult males with germ cell tumors.
    Gilligan TD, Seidenfeld J, Basch EM, Einhorn LH, Fancher T, Smith DC, Stephenson AJ, Vaughn DJ, Cosby R, Hayes DF, American Society of Clinical Oncology.
    J Clin Oncol; 2010 Jul 10; 28(20):3388-404. PubMed ID: 20530278
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.